ABSTRACT Single cells were prepared from guinea pig tracheal smooth muscle and used in binding studies of [3H]p-aminoclonidine. Specific binding of [3H]p-aminoclonidine was saturable to a single class of receptors, with an equilibrium dissociation constant (KD) of 1.62 ± 0.17 nM and a density (Bmax) of 6.20 ± 0.78 X 104 sites/cell. Competition studies were carried out with several adrenergic antagonists. The rank order of potency was idazoxan = phentolamine > yohimbine > prazosin = corynanthine. These results suggest that the a2-adrenoceptor in guinea pig tracheal smooth muscle represents a single pharmacological subtype, which is designated as a 2D.
Takagi et al. first reported in 1967 that guinea pig tracheal smooth muscle contains a-adrenoceptors (1) . Recently Takayanagi and co-workers (2-4) reported the existence of a 2-adrenoceptors in the guinea pig trachea with which norepinephrine interacts and re leases excitatory prostaglandins, mainly prostaglandin F2a, to contract tracheal muscles. There is now phar macological and molecular evidence that a2-adreno ceptors are not a homogenous population. Based on the pharmacological characteristics of receptors ex pressed in various tissues, a2-adrenoceptors have been classified into three subtypes: a2A, a2B and a2C (5); and thereafter, Simonneaux et al. (6) have reported the presence of an a 2D-adrenoceptor subtype in bovine pineal gland. Remaury and Paris also have found the a 2D-adrenoceptor subtype in an insulin-secreting cell line (RINm5F) on the basis of the rank order of po tency obtained from displacement curves of [3H]idazoxan binding by drugs (idazoxan = phentolamine > yohim bine = rauwolscine > prazosin).
In the present study, to clarify the a2-adrenoceptor subtype in guinea pig tracheal smooth muscle, the abil ity of several antagonists to inhibit the binding of
[3H]p-aminoclonidine was tested.
Single smooth muscle cells from guinea pig trachea were prepared by the method of Momose and Gomi (7), with some modifications, which was described in the previous report (8) . The [3H]p-aminoclonidine bind ing assay was performed with these single cells. Single cells were incubated with various concentrations of
[3H]p-aminoclonidine in a total volume of 0.3 ml of in cubation medium at 22°C for 60 min. The incubation mixture was rapidly filtered through a Whatman GF/B glass filter, and then the filter was washed 3 times with 3 ml of ice-cold 50 mM Tris/HCl buffer (pH = 7.4). The filter was dried and radioactivity was determined in a toluene base scintillator in a liquid scintillation spec trometer (Aloka LSC-900). Nonspecific binding was de termined as the radioactivity bound to the single cells that was not displaced by 10,uM phentolamine. Specific binding was determined as the difference between total binding and nonspecific binding. All assays were done in duplicate.
The apparent dissociation constant (KD) and max imum number of binding sites (Bmax) for [3H]p-amino clonidine were estimated by Scatchard analysis of the saturation data over a concentration range of 0.5-4.0 nM (9) . The ability of antagonists to inhibit specific
[3H]p-aminoclonidine binding was expressed as the IC50 value, which was the molar concentration of unlabeled drug necessary to displace 50% of the specific binding. To determine the subtype of the labeled sites, differ ent adrenergic antagonists were tested for their ability to inhibit [3H]p-aminoclonidine binding ( Fig. 1 and Table 1 ). Inhibition curves by antagonists yielded a Hill coefficient of unity, which is indicative of a single-site interaction. The K, values were obtained from curve fit ting according to the one-site inhibition model. Of the series of compounds tested, idazoxan displayed the highest affinity. Its K; value was higher than that of yohimbine, indicating that it has a high affinity towards a2D-receptor (11) . The rank order of potency for inhibition by drugs was idazoxan = phentolamine > yohimbine > prazosin = corynanthine ( Table 1 ). The rank order of potency for inhibition was consistent with results obtained from binding experiments using a2 adrenergic drugs (11, 12) . (13) . More than 90% of the single cells prepared from tracheal smooth muscle with our method were contracted by carbachol. These observations indicate that single cells prepared from guinea pig trachea are almost solely smooth muscle cells and do not include connective tis sue and epithelium. Using binding studies, the present report demonstrates that excitatory adrenoceptors in guinea pig tracheal smooth muscle cells are the a2D subtype. Functional studies of tracheal strips indicated that norepinephrine and clonidine contracted the trachea preparations in a concentration-dependent man ner, and the maximum responses to clonidine and nor epinephrine were much greater than that to phenyl ephrine, an a 1-adrenoceptor stimulant (2). Simonneaux et al. (6) and Remaury and Raris (11) proposed that a 2-adrenoceptors can be subclassified into a 2A-, a 2B-, a 2c and a 2D-subtypes on the basis of differences in affinity for selective competitive antagonists. The pK; value (8.32) of yohimbine obtained from our experi ments was higher than that reported for the pineal gland (11), but was in good agreement with the value reported by Simonneaux et al. (6) . It is a possibility that the difference between the pK, values of these re ports is due to the distinctive characteristics of each ligand ([3H]RX821001 and [3H]rauwolscine). In the present study, we used [3H]p-aminoclonidine as the ligand. In Table 1 , the affinities of these adrenergic drugs for the guinea pig tracheal receptor are compared with their affinities for the known a2-adrenergic sub types. Prazosin had a low affinity, suggesting that the tracheal receptor is unlikely to be an a2B or a2c-re ceptor. Idazoxan and phentolamine clearly differentiate the guinea pig trachea receptors from the a 2A-subtype. These agents had pK, values of 9.06 and 8.77, respec tively, which are not characteristic of the a2A-subtype and higher than that of human C-10 clone reported by Simonneaux et al. (6) and Lanier et al. (12) . In addi tion to comparing the absolute affinities of the various drugs for the receptor subtypes, it is often useful to compare the ratio of the Ki values for two drugs. The ratio of phentolamine/yohimbine (0.34) was consistent with those of phentolamine/rawolscine (0.18 and 0.91) reported Simonneaux et al. (6) and was similar to the characteristic of a2D-adrenoceptor reported by Remaury and Paris (11). Remaury and Paris (11) and Lanier et al. (12) reported that the ratios of idazoxan/yohimbine were 0.10 and 0.11. These values were agreement with that of idazoxan/yohimbine (0.21) obtained from our experiment. These observations indicate that the a2 adrenoceptor in guinea pig tracheal muscle has the characteristics of the a 2D-adrenoceptor. In rat entero cytes and the cell line RINm5F, where the a2D-adreno ceptors were predominant, the rank order of potency was idazoxan = phentolamine > yohimbine = rauwols cine > prazosin (11) . As shown in Table 1 
